Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $584.82 million. The enterprise value is $778.30 million.
| Market Cap | 584.82M |
| Enterprise Value | 778.30M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | Aug 30, 2024 |
Share Statistics
MLAB has 5.41 million shares outstanding. The number of shares has increased by 0.47% in one year.
| Shares Outstanding | 5.41M |
| Shares Change (YoY) | +0.47% |
| Shares Change (QoQ) | -0.63% |
| Owned by Insiders (%) | 5.54% |
| Owned by Institutions (%) | 91.51% |
| Float | 5.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 198.75 |
| PS Ratio | 2.71 |
| Forward PS | 2.51 |
| PB Ratio | 4.02 |
| P/FCF Ratio | 14.07 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 18.72 |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 1.52.
| Current Ratio | 2.47 |
| Quick Ratio | 1.52 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | 5.33 |
| Interest Coverage | -47.38 |
Financial Efficiency
Return on equity (ROE) is -76.80% and return on invested capital (ROIC) is -73.54%.
| Return on Equity (ROE) | -76.80% |
| Return on Assets (ROA) | -41.20% |
| Return on Capital (ROIC) | -73.54% |
| Revenue Per Employee | $293,732 |
| Profits Per Employee | -$345,443 |
| Employee Count | 736 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.46 |
Taxes
| Income Tax | -21.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.14% in the last 52 weeks. The beta is 0.86, so MLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -14.14% |
| 50-Day Moving Average | 102.88 |
| 200-Day Moving Average | 100.88 |
| Relative Strength Index (RSI) | 60.14 |
| Average Volume (20 Days) | 51,126 |
Short Selling Information
The latest short interest is 201,209, so 3.72% of the outstanding shares have been sold short.
| Short Interest | 201,209 |
| Short Previous Month | 191,961 |
| Short % of Shares Out | 3.72% |
| Short % of Float | 3.86% |
| Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, MLAB had revenue of $216.19 million and -$254.25 million in losses. Loss per share was -$47.20.
| Revenue | 216.19M |
| Gross Profit | 133.25M |
| Operating Income | -269.95M |
| Pretax Income | -275.65M |
| Net Income | -254.25M |
| EBITDA | -238.38M |
| EBIT | -269.95M |
| Loss Per Share | -$47.20 |
Balance Sheet
The company has $28.21 million in cash and $221.70 million in debt, giving a net cash position of -$193.48 million or -$35.77 per share.
| Cash & Cash Equivalents | 28.21M |
| Total Debt | 221.70M |
| Net Cash | -193.48M |
| Net Cash Per Share | -$35.77 |
| Equity (Book Value) | 145.39M |
| Book Value Per Share | 26.88 |
| Working Capital | 65.04M |
Cash Flow
In the last 12 months, operating cash flow was $44.13 million and capital expenditures -$2.57 million, giving a free cash flow of $41.57 million.
| Operating Cash Flow | 44.13M |
| Capital Expenditures | -2.57M |
| Free Cash Flow | 41.57M |
| FCF Per Share | $7.72 |
Margins
Gross margin is 61.64%, with operating and profit margins of -124.87% and -117.60%.
| Gross Margin | 61.64% |
| Operating Margin | -124.87% |
| Pretax Margin | -127.50% |
| Profit Margin | -117.60% |
| EBITDA Margin | -110.26% |
| EBIT Margin | -124.87% |
| FCF Margin | 19.23% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.59%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.59% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.47% |
| Shareholder Yield | 0.13% |
| Earnings Yield | -43.47% |
| FCF Yield | 7.11% |
Analyst Forecast
The average price target for MLAB is $106.00, which is -1.96% lower than the current price. The consensus rating is "Buy".
| Price Target | $106.00 |
| Price Target Difference | -1.96% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of -0.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.75 |
| Piotroski F-Score | 4 |